Ironwood Pharmaceuticals Inc. IRWD
Super Investor & Insider
| Data filing | Data op. | Insider | Ruolo | Tipo | Prezzo | Quantità | Valore |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | 2026-06-16 | Mchugh Julie | Dir | Vendita | $3.73 | -21,571 | $80,460 |
| 2026-03-17 | 2026-03-17 | Denner Alexander J | Dir | Vendita | $3.05 | -6,725,000 | $20.5M |
| 2026-03-17 | 2026-03-17 | Denner Alexander J | Dir | Vendita | $3.31 | -5,800 | $19,198 |
| 2026-02-25 | 2026-02-24 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Vendita | $3.66 | +17,012 | $62,264 |
| 2026-02-25 | 2026-02-24 | Gaskins Tammi L | Chief Commercial Officer | Vendita | $3.66 | -11,239 | $41,135 |
| 2026-02-25 | 2026-02-24 | Mccourt Thomas A | Chief Executive Officer | Vendita | $3.66 | -103,526 | $378,905 |
| 2026-02-25 | 2026-02-24 | Martini Gregory S. | Chief Financial Officer | Vendita | $3.66 | -11,457 | $41,933 |
| 2026-02-25 | 2026-02-24 | Silver Ronald | Principal Accounting Officer | Vendita | $3.66 | -12,621 | $46,193 |
| 2026-02-25 | 2026-02-23 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Vendita | $3.81 | -15,570 | $59,322 |
| 2026-02-25 | 2026-02-23 | Gaskins Tammi L | Chief Commercial Officer | Vendita | $3.81 | -10,287 | $39,193 |
| 2026-02-25 | 2026-02-23 | Mccourt Thomas A | Chief Executive Officer | Vendita | $3.81 | -94,757 | $361,024 |
| 2026-02-25 | 2026-02-23 | Martini Gregory S. | Chief Financial Officer | Vendita | $3.81 | -10,487 | $39,955 |
| 2026-02-25 | 2026-02-23 | Silver Ronald | Principal Accounting Officer | Vendita | $3.81 | -11,552 | $44,013 |
| 2026-01-07 | 2026-01-05 | Silver Ronald | Principal Accounting Officer | Vendita | $4.60 | -35,416 | $162,914 |
| 2025-11-19 | 2025-11-17 | Gaskins Tammi L | Chief Commercial Officer | Vendita | $3.32 | -6,016 | $19,973 |
| 2025-08-13 | 2025-08-11 | Gaskins Tammi L | Chief Commercial Officer | Vendita | $0.84 | -1,316 | $1,105 |
| 2025-08-13 | 2025-08-11 | John Minardo | Chief Legal Officer | Vendita | $0.84 | -7,754 | $6,513 |
| 2025-08-13 | 2025-08-11 | Martini Gregory S. | Chief Financial Officer | Vendita | $0.84 | -1,265 | $1,063 |
| 2025-08-13 | 2025-08-11 | Silver Ronald | Principal Accounting Officer | Vendita | $0.84 | -2,846 | $2,391 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Ironwood Pharmaceuticals Inc. is a healthcare and pharmaceuticals company specializing in the development and commercialization of drugs for gastrointestinal conditions. Headquartered in Cambridge, Massachusetts, Ironwood focuses on designing novel treatments that address unmet medical needs, particularly for condition…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees100
TickerIRWD
Statistics
Market Cap$579.4M
Revenue (TTM)$296.2M
Net Income$24.0M
Net Margin8.1%
EPS$0.15
P/E5.85
P/S1.65
P/B-2.72
EV/EBITDA4.55
ROE-9.2%
Dividend Yield—
Price$3.52
Data: Twelve Data · Revenue = mcap / P/S